SMS Pharmaceuticals share price
You have to be logged in to add this to Watchlist.- ₹316.00(-1.51%)February 6, 2026 15:25:55 PM IST
- NSE
- BSE
- Vol : 173.26 K (NSE + BSE)Last 20 day avg : 290.47 K
SMS Pharmaceuticals is trading -1.51% lower at Rs 316.00 as compared to its last closing price. SMS Pharmaceuticals has been trading in the price range of 328.30 & 315.90. SMS Pharmaceuticals has given 3.24% in this year & 1.22% in the last 5 days. SMS Pharmaceuticals has TTM P/E ratio 25.36 as compared to the sector P/E of 23.40.The company posted a net profit of 25.31 Crores in its last quarter.Listed peers of SMS Pharmaceuticals include Divi's Laboratories (-1.78%), Dr Reddy's Laboratories (-0.29%), Cipla (-0.14%).The Mutual Fund holding in SMS Pharmaceuticals was at 3.21% in 31 Dec 2025. The MF holding has increased from the last quarter. The FII holding in SMS Pharmaceuticals was at 0.04% in 31 Dec 2025. The FII holding has decreased from the last quarter.
- Overview
- Financials
- Forecast
- Technical Analysis
- Peers
- Shareholding
- About the company
- FAQ
Overview
Updated on Feb 07, 2026, 05:00 PM UTC
- BetaHigh volatility1.30Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
- Debt To EquityHigher than industry0.49The debt-to-equity ratio, indicating a company's financial leverage.
- Dividend YieldLower than industry0.12Annual dividends as a percentage of the stock price.
- PEG RatioIndicates overvaluation9.33The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
- P/E-Price-to-earnings ratio based on trailing 12-month earnings
- P/B-The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
|
| ||||
|
| ||||
Names | Technical rating | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
|---|---|---|---|---|---|---|---|---|
| Divi's Laboratories | Bearish | 6,027.00 | -1.78 | 1,60,509.28 | 78.61 | 11.52 | 0.46 | 0.01 |
| Dr Reddy's Laboratories | Neutral | 1,241.60 | -0.29 | 1,03,622.86 | 18.63 | 3.14 | 0.63 | 2.34 |
| Cipla | Moderately Bearish | 1,330.80 | -0.14 | 1,07,490.21 | 22.95 | 3.87 | 0.87 | 0.81 |
| Torrent Pharmaceuticals | Neutral | 3,931.65 | -1.04 | 1,33,059.55 | 67.32 | 17.1 | 0.83 | 17.62 |
| Sun Pharmaceutical Industries | Neutral | 1,694.90 | -0.43 | 4,06,653.70 | 36.24 | 5.77 | 0.92 | 0.50 |
- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
|---|---|
| 2026-02-07 | Quarterly Results |
| 2025-11-08 | Quarterly Results |
| 2025-08-09 | Quarterly Results & Others |
| 2025-05-30 | Audited Results & Final Dividend |
| 2025-02-12 | Quarterly Results & Others |
- IndustryBiotechnology & Drugs
- ISININE812G01025
- BSE Code532815
- NSE CodeSMSPHARMA
SMS Pharmaceuticals is trading at 316.00 as on Fri Feb 06 2026 09:55:55. This is -1.51% lower as compared to its previous closing price of 320.85.
The market capitalization of SMS Pharmaceuticals is 2956.18 Cr as on Fri Feb 06 2026 09:55:55.
The 52 wk high for SMS Pharmaceuticals is 359.95 whereas the 52 wk low is 175.00
SMS Pharmaceuticals can be analyzed on the following key metrics -
- TTM P/E: 25.36
- Sector P/E: 23.40
- Dividend Yield: 0.12%
- D/E ratio: 0.44
SMS Pharmaceuticals reported a net profit of 69.14 Cr in 2025.
The Mutual Fund Shareholding was 3.21% at the end of 31 Dec 2025.
EQUITY QUICK LINKS
SMS Pharmaceuticals QUICK LINKS
FROM MARKETS
RELATED LINKS
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.